Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: Its usefulness as a diagnostic marker for follicular and papillary carcinomas
- 1 January 1992
- journal article
- Published by Elsevier in Human Pathology
- Vol. 23 (1) , 21-25
- https://doi.org/10.1016/0046-8177(92)90005-n
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Expression of Keratin 19 Distinguishes Papillary Thyroid Carcinoma from Follicular Carcinoma and Follicular Thyroid AdenomaAmerican Journal of Clinical Pathology, 1989
- Application of immunohistologic staining to develop a malignant index to aid in distinguishing benign from malignant prostatic tissueThe Prostate, 1988
- Small round blue cell sarcoma of bone mimicking atypical Ewing's sarcoma with neuroectodermal features. An analysis of five cases with immunohistochemical and electron microscopic supportCancer, 1987
- Differential immunohistochemical reactions of carcinoid tumorsHuman Pathology, 1987
- Expression of neural-tissue markers (S-100 protein and Leu-7 antigen) by sweat gland tumors of the skin: An immunohistochemical studyJournal of the American Academy of Dermatology, 1987
- Anti‐Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinomaHistopathology, 1987
- Monoclonal antibody (anti‐leu 7) directed against natural killer cells reacts with normal, benign and malignant prostate tissuesInternational Journal of Cancer, 1985
- The natural-killer-cell-associated HNK-1 (Leu-7) antibody reacts with hypertrophic and malignant prostatic epitheliumCancer, 1985
- A shared antigenic determinant between natural killer cells and nervous tissueNature, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981